SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-033102
Filing Date
2024-02-13
Accepted
2024-02-13 10:17:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 BARINTHUS BIOTHERAPEUTICS PLC d778639dsc13ga.htm SC 13G/A 33565
2 GRAPHIC g778639g61w35.jpg GRAPHIC 8568
3 GRAPHIC g778639g63h39.jpg GRAPHIC 8294
  Complete submission text file 0001193125-24-033102.txt   48042
Mailing Address 10 FENCHURCH AVENUE LONDON X0 EC3M 5AG
Business Address 10 FENCHURCH AVENUE LONDON X0 EC3M 5AG 02075482293
M&G INVESTMENT MANAGEMENT LTD (Filed by) CIK: 0000922898 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Subject) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93002 | Film No.: 24623187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)